Browsing by Author O'Brien, Philippa M.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2009Expression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patientsMadigan, Michele; Beretov, J; Chen, Hongmin; Li, Yong; Liu, FengHua; O'Brien, Philippa M.; Patterson, K I; Wang, Li; Central Clinical School: Clinical Ophthal & Eye HealthExpression of urokinase plasminogen activator and its receptor in advanced epithelial ovarian cancer patients, Gynecologic oncology, vol.114, 2,pp 265-272
2006Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries.Baron-Hay, Sally; Scolyer, Richard; Scott, Carolyn; Biankin, Andrew V.; Fink, Daniel; Gardiner-Garden, Margaret; Hacker, Neville F.; Heinzelmann-Schwarz, Viola A.; O'Brien, Philippa M.; Scurry, Jame P.; Smith, Alison N.; Sutherland, Robert L.; Ward, Robyn N.; Clinical Schools; Central Clinical School: Pathology; Northern Clinical School: Molecular Medicine (Kolling I)Low meprin alpha expression differentiates primary ovarian mucinous carcinoma from gastrointestinal cancers that commonly metastasise to the ovaries., Journal of Clinical Pathology 2005, vol.60,(6),2006,pp 622-626
2010MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcomeByrne, Jennifer; deFazio, Anna; Emmanuel, Catherine; Fanayan, Susan; Murali, Rajmohan; Gloss, B; Hacker, Neville F.; Hardy, Jayne; Maleki, Sanaz; O'Brien, Philippa M.; Scurry, James P.; Sutherland, Robert L.; Children's Hospital Westmead: Paediatrics & Child Health; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Northern Clinical School: Kolling Institute; Central Clinical School: PathologyMAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome, BMC Cancer, vol.10, 497,pp 1-11